Used in pharmaceutical research as a key intermediate for synthesizing bioactive compounds targeting neurological disorders. Shows potential in the development of dopamine receptor modulators, particularly for treating Parkinson’s disease and schizophrenia. Its rigid polycyclic structure enhances binding selectivity, improving drug efficacy and reducing off-target effects. Also explored in positron emission tomography (PET) tracer design due to favorable brain penetration and metabolic stability.